Calamos Advisors LLC Buys Shares of 2,700,000 Kenvue Inc. $KVUE

Key Points

• Calamos Advisors LLC bought a new stake of 2,700,000 Kenvue shares in Q4, valued at about $46.6 million and representing roughly 0.14% of the company.
• Wall Street's consensus rating on KVUE is Hold with an average price target of $19.33 after recent analyst moves (Jefferies and Barclays cut targets toward $18 while a few firms maintain Buy ratings).
• Kenvue beat recent quarterly estimates (EPS $0.27 vs. $0.22; revenue $3.78B) and pays a quarterly dividend yielding about 4.7%, though its payout ratio is around 107.8%.

Calamos Advisors LLC bought a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,700,000 shares of the company's stock, valued at approximately $46,575,000. Calamos Advisors LLC owned about 0.14% of Kenvue as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in Kenvue by 27.1% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 310,686 shares of the company's stock valued at $5,042,000 after buying an additional 66,192 shares during the last quarter. Renaissance Capital LLC lifted its stake in Kenvue by 55.8% in the third quarter. Renaissance Capital LLC now owns 980,436 shares of the company's stock valued at $15,912,000 after buying an additional 351,259 shares during the last quarter. Allstate Corp bought a new stake in Kenvue in the third quarter valued at $1,152,000. Aberdeen Group plc lifted its stake in Kenvue by 84.1% in the third quarter. Aberdeen Group plc now owns 1,411,380 shares of the company's stock valued at $22,914,000 after buying an additional 644,930 shares during the last quarter. Finally, Oak Thistle LLC bought a new stake in Kenvue in the fourth quarter valued at $1,563,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on KVUE shares. Jefferies Financial Group cut Kenvue from a "buy" rating to a "hold" rating and cut their target price for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Canaccord Genuity Group raised their target price on Kenvue from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Wednesday, February 18th. Weiss Ratings reissued a "hold (c-)" rating on shares of Kenvue in a report on Wednesday, April 8th. Argus raised Kenvue to a "hold" rating in a report on Friday, March 6th. Finally, Barclays lowered their price target on Kenvue from $19.00 to $18.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 14th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $19.33.

Kenvue Price Performance

Shares of KVUE opened at $17.49 on Friday. The firm has a market capitalization of $33.57 billion, a price-to-earnings ratio of 22.71, a price-to-earnings-growth ratio of 3.97 and a beta of 0.61. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The stock's fifty day moving average is $17.82 and its 200-day moving average is $17.15.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.22 by $0.05. The company had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company's quarterly revenue was up 3.2% compared to the same quarter last year. During the same period last year, the company earned $0.26 earnings per share. Equities analysts anticipate that Kenvue Inc. will post 1.1 EPS for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue's payout ratio is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.